Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Anna Byrd"'
1
Akademický článek
Characterizing the Prevalence of Obesity Misinformation, Factual Content, Stigma, and Positivity on the Social Media Platform Reddit Between 2011 and 2019: Infodemiology Study
Autor: Catherine C Pollack, Jennifer A Emond, A James O'Malley, Anna Byrd, Peter Green, Katherine E Miller, Soroush Vosoughi, Diane Gilbert-Diamond, Tracy Onega
Publikováno v: Journal of Medical Internet Research, Vol 24, Iss 12, p e36729 (2022)
BackgroundReddit is a popular social media platform that has faced scrutiny for inflammatory language against those with obesity, yet there has been no comprehensive analysis of its obesity-related content. ObjectiveWe aimed to quantify the presence
Externí odkaz: https://doaj.org/article/d2b31504ca9743ef869a9285009dfe8e
Zobrazit plný text záznamu
2
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome
Autor: Guillermo Garcia-Manero, Monica Kwari, Zeev Estrov, Gautam Borthakur, Varsha Gandhi, Farhad Ravandi, Anna Byrd, Elias Jabbour, Hagop M. Kantarjian, Jorge E. Cortes, Stefan Faderl
Publikováno v: Cancer. 118:722-728
BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m2 vs 3
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d17520360339c4320e345c800b1b99e
https://doi.org/10.1002/cncr.26327
Zobrazit plný text záznamu
3
Oral Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome
Autor: Anna Byrd, Varsha Gandhi, Hagop M. Kantarjian, Gautam Borthakur, Monica Kwari, William Plunkett, Jorge E. Cortes, Farhad Ravandi, Zeev Estrov, Guillermo Garcia-Manero, Susan O'Brien, Stefan Faderl
Publikováno v: Journal of Clinical Oncology. 28:2755-2760
Abstract 118 Clofarabine (CLO) is a second generation deoxyadenosine nucleoside analog with activity in patients (pts) with acute myeloid leukemia (AML). Early reports also suggestedactivity of iv CLO in myelodysplastic syndrome (MDS), but the role o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d836c0ae93e62fb3acd2c3a3da6c4d
https://doi.org/10.1200/jco.2009.26.3509
Zobrazit plný text záznamu
4
A Culture of Success—Examining School Culture and Student Outcomes via a Performance Framework
Autor: Matthew Ohlson, Anna Byrd, Anne Swanson, Andrea Adams-Manning
Publikováno v: Journal of Education and Learning. 5:114
This study is a report of the relationship between a collaborative school culture, teacher quality and the influence these variables have upon student attendance and suspensions. The research is based upon data gathered from 50 public schools through
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f090bcf5399ef183125020fd1149364
https://doi.org/10.5539/jel.v5n1p114
Zobrazit plný text záznamu
6
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
Autor: Farhad Ravandi, Guillermo Garcia-Manero, Anna Byrd, Michael Andreeff, B. Nebiyou Bekele, Sherry Pierce, Susan O'Brien, Gautam Borthakur, Dan Jones, Mark J. Levis, Zeev Estrov, Marina Konopleva, Stefan Faderl, Deborah A. Thomas, Hagop M. Kantarjian, Keith W. Pratz, Jorge E. Cortes, Rajyalakshmi Luthra, Mark Brandt
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(11)
Purpose To determine the efficacy and toxicity of the combination of sorafenib, cytarabine, and idarubicin in patients with acute myeloid leukemia (AML) younger than age 65 years. Patients and Methods In the phase I part of the study, 10 patients wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e059a7a2c0eb75637862b1af68d411
https://pubmed.ncbi.nlm.nih.gov/20212254
Zobrazit plný text záznamu
7
Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
Autor: Marina Konopleva, Farhad Ravandi, Gautam Borthakur, Hagop M. Kantarjian, Stefan Faderl, Alessandra Ferrajoli, Kiran Naqvi, Anna Byrd, Charles Koller, Deborah A. Thomas, Monica Kwari
Publikováno v: Blood. 116:1061-1061
Abstract 1061 Clofarabine is a second generation nucleoside analog with activity in patients with acute leukemias. Previous studies with the combination of clofarabine plus cytarabine have reported a complete remission rate (CR) of 24% in relapsed AM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f0998cfc5c921d43e49fce0f54cabd1
https://doi.org/10.1182/blood.v116.21.1061.1061
Zobrazit plný text záznamu
8
A randomized study of two dose levels of intravenous (IV) clofarabine (CLO) in the treatment of patients (pts) with higher-risk myelodysplastic syndrome (MDS)
Autor: Varsha Gandhi, Anna Byrd, Stephan Faderl, Monica Kwari, F. Ravandi Kashani, E. Jabbour, Zeev Estrov, G. Garcia-Manero, Hagop M. Kantarjian, G. Borthakur
Publikováno v: Journal of Clinical Oncology. 28:6504-6504
6504 Background: CLO is a second-generation deoxyadenosine nucleoside analog with activity in pts with AML. Early reports also suggested activity in MDS. Methods: We designed an adaptively randomiz...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83b8c4575a01ca2a148a568ce27b0e44
https://doi.org/10.1200/jco.2010.28.15_suppl.6504
Zobrazit plný text záznamu
9
Pharmacodynamic Study of Phase 1/2 Trial of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Chemotherapy in Patients with Relapsed/Refractory AML
Autor: Duncan H. Mak, Michael Andreeff, Anna Byrd, Elihu H. Estey, Stephen Morris, Marina Konopleva, Bing Z. Carter, Hagop M. Kantarjian, Gautam Borthakur
Publikováno v: Blood. 112:1943-1943
XIAP, a potent cellular inhibitor of caspases 3 and 9, is highly expressed in various malignant cells including AML cells and contributes to chemoresistance. A phase 1/2 trial of the XIAP antisense oligonucleotide AEG35156 in combination with chemoth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5bc27f6438a992ee9eb6cf11469a5842
https://doi.org/10.1182/blood.v112.11.1943.1943
Zobrazit plný text záznamu
10
Oral (po) and Intravenous (iv) Clofarabine for Patients (pts) with Myelodysplastic Syndrome (MDS)
Autor: Zeev Estrov, Hagop M. Kantarjian, Deborah A. Thomas, Guillermo Garcia-Manero, Varsha Gandhi, Anna Byrd, Farhad Ravandi, William Plunkett, Stefan Faderl, Gautam Borthakur, Monica Kwari
Publikováno v: Blood. 112:222-222
Clofarabine (CLO) is a second generation deoxyadenosine nucleoside analog with activity in pts with acute myeloid leukemia (AML). Early reports also suggested activity in MDS, but the role of CLO in MDS has not been defined. To evaluate the activity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f492602585b3f0ddaa5b1c8d04c2783
https://doi.org/10.1182/blood.v112.11.222.222
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje